Alejandro Galindo's Insider Trades & SAST Disclosures
Alejandro Galindo's most recent trade in Mannkind Corp was a trade of 4,600 Common Stock, $0.01 Par Value done at an average price of $3.9 . Disclosure was reported to the exchange on Aug. 22, 2022.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Alejandro Galindo.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mannkind Corp | Alejandro Galindo | EVP Endocrine Business Unit | Sale of securities on an exchange or to another person at price $ 3.85 per share. | 22 Aug 2022 | 4,600 | 777,090 (0%) | 0% | 3.9 | 17,713 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Alejandro Galindo | EVP Endocrine Business Unit | Sale of securities on an exchange or to another person at price $ 3.87 per share. | 22 Aug 2022 | 15 | 777,075 (0%) | 0% | 3.9 | 58 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Alejandro Galindo | EVP Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 2.93 per share. | 31 Jul 2022 | 5,000 | 781,690 (0%) | 0% | 2.9 | 14,650 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Alejandro Galindo | EVP Endocrine Business Unit | 18 May 2022 | 4,789 | 776,690 (0%) | 0% | 3.2 | 15,277 | Common Stock, $.01 Par Value | |
| Mannkind Corp | Alejandro Galindo | EVP Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 110,000 | 776,690 | - | 0 | Restricted Stock Unit | |
| Mannkind Corp | Alejandro Galindo | EVP Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 90,000 | 666,690 | - | 0 | Restricted Stock Unit | |
| Mannkind Corp | Alejandro Galindo | EVP Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 2.71 per share. | 28 Feb 2022 | 36,900 | 576,690 (0%) | 0% | 2.7 | 99,999 | Common Stock,$.01 par value |
| Mannkind Corp | Alejandro Galindo | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 2.71 per share. | 28 Feb 2022 | 36,900 | 576,690 (0%) | 0% | 2.7 | 99,999 | Common Stock,$.01 par value |
| Mannkind Corp | Alejandro Galindo | EVP Endocrine Business Unit | Grant, award, or other acquisition of securities at price $ 3.17 per share. | 31 Jan 2022 | 1,804 | 539,790 (0%) | 0% | 3.2 | 5,719 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Alejandro Galindo | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 3.17 per share. | 31 Jan 2022 | 1,804 | 539,790 (0%) | 0% | 3.2 | 5,719 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Alejandro Galindo | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 2.99 per share. | 30 Jul 2021 | 5,000 | 547,602 (0%) | 0% | 3.0 | 14,950 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Alejandro Galindo | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 79,000 | 542,602 | - | 0 | Restricted Stock Unit | |
| Mannkind Corp | Alejandro Galindo | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2021 | 65,000 | 463,602 | - | 0 | Restricted Stock Unit | |
| Mannkind Corp | Alejandro Galindo | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 2.89 per share. | 08 Dec 2020 | 34,602 | 398,602 (0%) | 0% | 2.9 | 100,000 | Common Stock, $0.01 Par Value |
| Mannkind Corp | Alejandro Galindo | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2020 | 200,000 | 364,000 | - | 0 | Restricted Stock Unit | |
| Mannkind Corp | Alejandro Galindo | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Aug 2020 | 164,000 | 164,000 | - | 0 | Restricted Stock Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges